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Background: The barriers to HIV testing and counselling that migrants encounter can jeopardize proactive HIV
testing that relies on the fact that HIV testing must be linked to care. We analyse available evidence on HIV testing
and counselling strategies targeting migrants and ethnic minorities in high-income countries. Methods: Systematic
literature review of the five main databases of articles in English from Europe, North America and Australia
between 2005 and 2009. Results: Of 1034 abstracts, 37 articles were selected. Migrants, mainly from
HIV-endemic countries, are at risk of HIV infection and its consequences. The HIV prevalence among migrants is
higher than the general population’s, and migrants have higher frequency of delayed HIV diagnosis. For migrants
from countries with low HIV prevalence and for ethnic minorities, socio-economic vulnerability puts them at risk of
acquiring HIV. Migrants have specific legal and administrative impediments to accessing HIV testing—in some
countries, undocumented migrants are not entitled to health care—as well as cultural and linguistic barriers,
racism and xenophobia. Migrants and ethnic minorities fear stigma from their communities, yet community
acceptance is key for well-being. Conclusions: Migrants and ethnic minorities should be offered HIV testing,
but the barriers highlighted in this review may deter programs from achieving the final goal, which is linking
migrants and ethnic minorities to HIV clinical care under the public health perspective.
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Introduction
Migrant populations, largely from sub-Saharan Africa (SSA),represent a considerable proportion of HIV infections in
Europe and are heavily affected by late HIV diagnoses.1,2 A similar
situation occurs in ethnic minorities in the USA.3 In 2006, the US
Centers for Disease Control and Prevention published their revised
recommendations for HIV testing, which aimed for routine
voluntary HIV screening for all persons aged 13–64 years in
health-care settings independently of HIV risk assessment unless
the local HIV prevalence falls below 0.1%. Under the new recom-
mendations, neither pretest counselling nor separate signed consent
forms are required.3 Since then, other recommendations have been
issued to expand HIV testing and normalize testing.4–8 Although
increasing HIV testing at population level is a challenge, doing so
in migrants and ethnic minorities may pose additional difficulties.
Whereas some barriers to HIV testing are shared by other groups,
others, such as administrative,9–12 legal,1,13,14 language14–18 and
cultural barriers,9,11,14,16,18–20 are not. Some European Union (EU)
countries do not provide HIV care for people of uncertain legal
status. Therefore, the lack of any medical benefit for individuals
found to have HIV combined with the fear of deportation may
hinder public health initiatives promoting testing in migrants.21
The different epidemiological patterns of HIV infection in migrants
and ethnic minorities in Europe and the migrants’ unique barriers to
HIV testing and care may compromise proactive HIV testing
approaches that rely on the statement that HIV testing is linked to
care.4,5,22 Given that the translation of policies into practice requires
deep knowledge of target populations, we have conducted a systematic
review of the literature on HIV testing and counselling targeting
migrants living in high-income countries.
Methods
We performed a literature search in PubMed, EMBASE, CRD York
database, Cochrane and Web of Knowledge of articles published in
English between 2005 and 2009 in Europe, North America and
Australia. To be eligible, articles had to include at least one
keyword from: (i) ethnic groups, minority groups, transients and
immigrants, refugees; (ii) mass screening, diagnosis, AIDS
Serodiagnosis, public policy, prevention and control, Centers
for Disease Control and Prevention (USA), counselling; and
(iii) Acquired immunodeficiency syndrome, HIV, HIV Infections.
After piloting in 14 articles, the final data collection form included
information on year and country of the study, ‘migrants’ and ‘ethnic
minorities’ definition, setting, study design and sample size.
Information on gender, criminalization of HIV transmission and
legal consequences of HIV disclosure in migrants with uncertain
status was also collected.
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As described in figure 1, 1185 articles were identified; 151 were
duplicates. The remaining 1034 abstracts were read, and only
abstracts not referring to migrants or ethnic minorities in Europe,
USA, Canada and Australia and HIV testing and/or counselling were
eliminated at this stage; 970 articles were discarded and 64 selected
for full review.
Teams of two people read the 64 articles and applied eligibil-
ity criteria; 31 articles were rejected because they did not deal
with HIV testing (n = 22), they did not deal with migrants or
ethnic minorities (n = 13), countries did not meet criteria (n = 3)
or they were of poor quality (n = 1). The review of these 64
articles identified seven new manuscripts, from the manuscripts’
references, of which four met inclusion criteria. Final analyses
were based on 37 articles.
Results
Most studies were conducted in Anglo-Saxon countries—12 in USA,
4 in Canada, 13 in the UK—and 8 from other European countries.
None of the articles was from Australia. The majority (n = 35) was
conducted in one country, most (n = 20) with local scope. Studies
were conducted in health (n = 15) and community settings (n = 11)
(supplementary table). Overall, 25 studies (68%) used quantitative
methodology, two combined quantitative and qualitative method-
ology, six used qualitative methodology and four were literature
reviews. Operational definitions for ‘migrant’, ‘race’ or ‘ethnicity’
(understood as concept defining racial/ethnic minorities) were
present in all articles; more than one definition was often present;
14 defined migrants based on country of origin, 13 on country of
birth and 3 on nationality. With regards to race and ethnicity, eight
studies (mostly from USA) defined subjects on self-reported
ethnicity and nine on documented ethnicity (n = 7), ethnic origin
(n = 1) and race (n = 1).
Migrant populations studied were largely sub-Saharan
Africans,10,11,23–26 Latin Americans23 and South Asians20 in EU
countries, and Hispanics or Latinos,12,15,17,27–29 Africans16 and
Southeast Asians14 in the USA. Three articles from Canada studied
asylum seekers, visa applicants and refugees9,30,31, and one from the
USA studied adopted foreign children.19 The racial/ethnic minorities
were largely ‘Black communities’ in the UK.32–35 One study in the
USA refers to generic ‘racial minorities’.36
The 37 studies addressed heterogeneous aspects of HIV testing and
counselling in migrants and ethnic minorities, which could be
grouped as follows: (i) prevalence and risk factors for HIV infection;
(ii) barriers to HIV testing; (iii) HIV testing uptake; (iv) late HIV
diagnosis; and (v) interventions to encourage HIV testing.
Prevalence and risk factors for HIV infection in
migrants and ethnic minorities
Although our aim was not to systematically review HIV prevalence
and risk factors in migrants and ethnic minorities, this topic came
up frequently. Although many articles include general references to
this issue, studies that report data about differential prevalence of
HIV have been included in table 1. The groups identified as having
high HIV prevalence were sub-Saharan Africans in Europe, black
Africans and black Caribbeans in London and sub-Saharan
Africans, Latinos and blacks in USA.
Epidemiological patterns in countries of origin, together with
clinical presentations in countries of destination, led some authors
to conclude most HIV infections in migrants are imported. This
approach is largely applied to migrants from SSA in Europe
(Denmark,37 France,38 Spain18,23 and UK25,32,34) and Canada.9,30,31
Other studies consider some migrants may have acquired HIV
in countries of destination because of unfavourable environment
to fostering preventive behaviours.11,39,40 Some migrants are
described as having high-risk behaviours: multiple sexual partners,
low and inconsistent condom use, high alcohol consumption and
drug use.17,27–29
Migrant women and ethnic minority men who have sex with men
(MSM) are considered especially vulnerable; female migrants suffer
disproportionate burden of HIV infection derived from difficulties
negotiating condom use28 and sexual exploitation.31 The invisibility
of ethnic minority MSM, who go unnoticed by the stigma of being
MSM that would involve their country or ethnic group of origin, is
thought to be key to their vulnerability to HIV infection; they have
high HIV prevalence, unsafe sex39 and high prevalence of late HIV
diagnosis.14,35
Barriers to HIV testing in migrants and ethnic
minorities
Barriers to HIV testing exist at the structural, health-care provider,
health-care user and community levels.
Structural barriers to HIV testing relate to poor living conditions,
legal and administrative status and discrimination in countries of
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Figure 1 Flow diagram
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destination. High levels of unemployment and poverty in migrants
and ethnic minorities, low social status and inequalities are
mentioned as barriers to HIV testing and care.10,11,18–20,24 Legal
status, which ranks among the highest priorities, and concerns
about implications of testing positive are the main barriers in
studies from Canada, USA, Spain and the UK. According to these
studies, in contexts where an HIV diagnosis may adversely affect visa
or residence application or where there is a fear of deportation,
migrants are reluctant to be tested.10,11,13 Lack of entitlement to
health care for undocumented immigrants is another barrier,
largely but not exclusively, mentioned in the USA.13,14,35 Lack of
clarity among health-care providers on migrants’ rights to health
care is highlighted.24 Regarding stigma and discrimination, African
people tested for HIV in London in the 1990s were twice as likely as
whites to be concerned about being discriminated against.10
Structural racism is also mentioned by Fakoya et al.,24 who drew
attention to the disproportionate number of sub-Saharan Africans
prosecuted for allegedly transmitting HIV infection in the UK.
Within health-care structures, communication, language
problems and lack of cultural sensitivity and underinvestment in
culturally competent services lead to misconceptions about
migrants and minority groups by health-care providers.14–18,20
Some migrants and ethnic minorities prefer to visit medical practi-
tioners from their own community.19 Whereas some communities
are described as having good knowledge about where to go for HIV
testing, for example, sub-Saharan Africans in the UK,11 other studies
identify poor knowledge among migrant and ethnic minorities
regarding where to get tested for HIV anonymously and free of
charge.9–12 Other barriers at health-care user level include the low-
priority migrants assigned to health care11,13 and their low
perception of HIV risk10,12,14,35,41. Migrants give priority to basic
needs, but knowledge of their HIV status ranks low.13 Low HIV
risk perception at individual level is mentioned, even in people
with community risk awareness.10,12,14,35,41 Researchers note there
is often a gap between risk perception and individual risk
behaviours14; some studies describe low risk perception among
those who test HIV positive.10,11,41
At the community level, cultural and gender norms may dissuade
heterosexual men and women and MSM from seeking HIV testing.
Loss of status and community support and social isolation after
confidentiality gaps are among the main reasons given for not
testing.9–13,16,24,26,27,34,41,42 This is a particular concern for individ-
uals who need to bring a relative or friend to help with translation.19
Olshefsky et al.27 report ‘machismo’ as a barrier among Latino men;
Foley16 reports that women from SSA have difficulty seeking HIV
testing or treatment without partners’ approval and economic
support.
HIV testing uptake in migrants and ethnic minorities
Several studies describe an HIV testing uptake in migrants and
ethnic minorities to range from 21% to 73% in the USA and from
23% to 64% in Europe12,14,20,29,43 (table 2). Overall, a higher
proportion of ethnic minority and migrant women have been
tested for HIV compared with men; this is partially owing to
women’s acceptance of routine HIV screening during antenatal
care.29,33,42,44 However, beyond this, several studies support a
gender difference in HIV testing uptake, with migrant men being
not only less exposed to HIV testing but also less willing to be
tested.24
Table 1 HIV prevalence in migrants and ethnic minorities
Authors Country/Date Sample size Target population HIV prevalence/incidence Design
Monge-Maillo B
et al
Spain (2009) 2198 Immigrants referred to the
Tropical Medicine Unit of
Ramón y Cajal Hospital
(Madrid) over a 20-year period
Incidence: total population: 97
(4.4%); sub-Saharan Africans:
82 (5.2%); Latin Americans: 15
(2.4%)
Cross-sectional study
Forbes KM et al. UK (2008) 30 Patients attending an outreach
clinic for those <25 years
between June and October
2007, in an area where black
and minority ethnic groups
comprise the majority of the
local population
There were no cases of HIV A retrospective case-notes review
was undertaken of those
attending community-based
sexual health services. (Note:




Canada (2006) 634 958 All applicants in Canada, 15 years




Prevalence of 3% among
applicants from six African
countries (Zimbabwe, Burundi,
Rwanda, Uganda, Zambia and
Chad)
National data collected by Public
Health Agency of Canada
Schmid J et al. Denmark (2005) Does not know
(Unknown) (DK)
Children <16 years in Denmark in
2003
Incidence: 89 (5.77 per 100 000
children). Of these 89 newly
diagnosed: 48% born in
Denmark 43% in Africa and
9% in other places
Data from the national surveil-
lance system and HIV-infected
children from the Danish
Paediatric HIV Cohort Study
MacPherson DW
et al.
Canada (2006) 256 970 Residency applicants <15 years of
age between 2002 and 2005
36 (0.014%), most of them from
Africa (89%)





Spain (2009) 1609 Immigrants referred to the
Tropical Medicine Unit of
Ramón y Cajal Hospital
(Madrid) during 1997–2006






Dougan, S et al. UK (2005) 1040 Men who have sex with men
aged 16–44 years in England
and Wales in 2002
Prevalence: 7.4% black and
minority ethnic MSM; 3.2%
white MSM
Cross-sectional study with the
data from the Survey of
Prevalent HIV Infections
Diagnosed that estimates the
number of individuals living
with diagnosed HIV infection
in England and Wales (E&W)
since 1995
HIV testing for migrant populations in high-income countries 1041








Table 2 Uptake of HIV test in migrants and ethnic minorities
Authors Country/Date Sample
size
Target population Test prevalence/test acceptance
prevalence
Design
Forbes KM et al. UK (2008) 117 Outreach clinic for those <25
years in an area where black
and minority ethnic groups
comprise the majority of the
local population
23% ever tested A retrospective case-notes review
was undertaken of those
attending community-based
sexual health services. (Note:
not clear whether all respond-
ents were from minorities)
Conaty SJ et al. UK (2005) 443 Sub-Saharan women in antenatal
care
86% accepted an HIV test Cross-sectional study. HIV test
acceptance. (Note: prevalence
calculated by our research
team based on presented
article data)
Fernandez MI et al. USA (2005) 244 Hispanic migrant/seasonal farm
workers in southern
Miami-Dade County, Florida
21% (51/244) had been tested for
HIV; 39% (94/244) declared
they would accept on the day
of the interview; 69% (134/193
never tested) declared they
would accept if recommended
by a provider
Cross-sectional study: questions
about HIV test performance
and intention to test
Sadler KE et al. UK (2006) 114 Black Africans (>16 years old)
living in London
82% (93/114) accepted HIV
testing in the survey
Cross-sectional study with offer
of HIV test
Dowling T et al USA (2007) 627 Participants at black gay,
Hispanic gay or gay pride
events
24% (133) of those with
unknown or negative HIV
status (543) accepted HIV
testing
Cross-sectional study with offer
of HIV test. (Note: not clear if
all respondents were from
ethnic minorities. Of all
persons willing to be tested,
not all were finally tested for
several reasons, mainly
resource limitations)
Ostermann J et al. USA (2007) 146 868 Adult participants in the survey
aged 18–64 years
Tested in past 12 months (by
ethnicity): white non-Hispanic,
8.1%; black non-Hispanic,
19.0%; Hispanic, 11.7%; Other,
9.6%. Plan to test in next 12
months: white non-Hispanic,
5.2%; black non-Hispanic,
19.8%; Hispanic, 12.7%; Other,
7.1%
Cross-sectional analysis of data
from 146 868 participants aged
18–64 years in the 2000–05
National Health Interview
Surveys, HIV test in the past
Tariq S et al. UK (2007) 458 Cases were defined as the first
125 new Genito-Urinary (GU)
clinic attendees who
self-identified as South Asian.




Ever tested: cases: 60% (148/229);
controls: 64% (154/229)
A retrospective case–control
study was performed at a GU
Clinic in London: HIV test in
the past
Huang ZJ et al. USA (2008) 604 Self-identified as Cambodian,
Laotian or Vietnamese; >18
yearsold and residents in
Washington, DC
Ever tested: total sample, 31%
(186/604); Laotians, 22% (44/
196); Vietnamese, 37% (72/
197); Cambodians, 38% (79/
211)
Cross-sectional study. Have had
an HIV test
Southgate J et al. UK (2008) 1586 Pregnant women from ethnic
minority groups
Prevalence ratio of HIV test
acceptance: white, 91% (1094/
1214); black African, 92% (145/







USA (2005) 4261 Hispanic subgroups living in the
USA
Ever tested: total sample, 34%
(1444/4261); Puerto Ricans,
44% (197/444); Mexicans, 28%
(419/1480); Mexican
Americans, 33% (355/1079);
Cubans + Cuban Americans,
29% (80/277); Central/South
Americans, 41% (259/640);
other Hispanics, 39% (133/341)
Cross-sectional study. Have had
an HIV test (Note: prevalence
by our research team based on
presented article data)
Dougan S et al. UK (2005) 1040 Black and minority ethnic men
who have sex with men in
England and Wales





(473/870); Asia, 56% (417/739)
Cross-sectional study with offer
of HIV test
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The context in which testing is offered and who offers the test
seem to be important determinants of test acceptance. For example,
in a US study, 70% of Hispanic migrant farm workers reported they
would accept testing recommended by a health-care provider, with
women more likely than men to accept testing.29 In contrast, MSM
from ethnic minorities in the USA were more prone to accept HIV
testing outside health settings; rapid HIV testing of MSM in racial/
ethnic minority groups in settings such as gay pride events is a useful
way to enable HIV-infected MSM to learn their HIV status.
Late HIV diagnosis in migrants and ethnic minorities
High prevalence of delayed diagnosis of HIV infection in migrants
and ethnic minorities was reported, largely among sub-Saharan
Africans in the UK,10,11,13,24,25,40 Spain23 and France38 and among
Latinos and Asian Americans in the USA14,27 and Canada.45
López-Quintero et al.12 report Hispanics to be more likely to have
delayed HIV diagnoses than whites and Afro-Americans. Prost et
al.10 cite the Health Protection Agency and the Mayisha II
Study,46 which estimated that by 2005, approximately 21 500
Africans were living with HIV in the UK and that one-third of
them were undiagnosed. Fakoya et al.24 report that most people
from sub-Sahara diagnosed with HIV in the UK acquired the
infection in the countries of origin and tend to present with
advanced disease. Also in the UK, Chadborn et al.13 report high
prevalence of late diagnosis in heterosexual whites (36%), black
Caribbeans (36%) and black Africans (43%). They describe lower
rates of delayed diagnosis in women diagnosed through antenatal
testing than other people diagnosed elsewhere. For sub-Saharan
Africans, late diagnosis was present in 21% of women diagnosed
during antenatal care, 44% of women diagnosed elsewhere and
50% of men. In France, although women were less likely to be
diagnosed late because of routine prenatal testing, this was not the
case among migrants. Acquisition of HIV infection at early ages
before arrival to France could underlie these differences.38
Interventions to encourage HIV testing in migrants
and ethnic minorities
The literature identified two main approaches to HIV testing:
general population approaches in health-care settings and targeted
approaches directed to at-risk populations, including migrant
and/or ethnic minorities. In both cases, specific interventions to
encourage the participation of migrants and ethnic minorities are
discussed. Among the targeted approaches, voluntary or compulsory
HIV testing strategies are analysed.
Antenatal screening is an example of a population-wide approach;
various studies support routine antenatal testing for all pregnant
women as an effective strategy for achieving good coverage of HIV
testing in migrant and ethnic minorities.42 Regarding preferences of
immigrant women, a study in Canada found that women from
HIV-endemic countries prefer non-targeted strategies integrated
within health services.9 Some countries have taken targeted
approaches to HIV testing in antenatal care. For example,
Denmark switched from routine to HIV selective antenatal
screening in 1995; HIV testing was only offered to women from
high prevalence countries since almost all HIV-positive pregnant
women identified were migrants or married to migrants from high
prevalence countries.37 However, a few HIV-positive babies were
born subsequently, resulting in the reintroduction of universal
screening.
Health-care provider endorsement was identified as a significant
predictor of HIV testing. Some authors recommend mixed
approaches; introducing HIV screening in routine medical practice
in addition to targeted strategies in place, particularly in areas
with high HIV prevalence and a concentration of migrant
population.9,29,41,42
Many authors indicated that culturally sensitive HIV testing and
counselling interventions are needed to improve institutional access
to health services to promote HIV testing among migrants and
ethnic minorities.9,11,29 Community partnerships and participation
are identified as critical to increase testing uptake. A UK study calls
for community involvement in promoting testing along with the
benefits of accessing antiretroviral therapy.11 Provision of testing
services in client’s language is also mentioned.9,17
Innovative targeted approaches to reach people who might not
otherwise use testing services include the provision of HIV rapid
testing in non-traditional health-care settings outside normal
working hours.29 Provision of point-of-care testing by non-
government and community-based organizations and testing by
outreach services, mobile clinics and in venues such as barber
shops and hair salons, social clubs, sporting events or street
corners27,36 are recommended. Offering HIV testing at gay pride
events36, saunas41 and other venues was also considered to
increase uptake among MSM.
Another approach specifically targeting migrants is screening on
arrival in the country. US policy requires HIV testing for asylum
seekers,47 and in 2008, when the mentioned article was published,
those who were HIV-infected could only obtain temporary
admission to the USA. Children who arrive in the USA needing a
permanent visa are required to be screened for HIV, hepatitis B and
C and tuberculosis, and screening is repeated 6 months after arrival.
The implications of HIV test results for visa status are not
discussed.19 HIV testing is also mandatory for migrants and
asylum seekers entering Canada. Screening includes clinical referral
and information that is sensitive to the gender, cultural and
linguistic profile of the client.30,31 This approach is reported to
have resulted in an increased number of cases of HIV diagnosed
in immigrants and uptake of health care in this country.45 A
French study recommends offering HIV testing to migrants on
arrival to reduce late diagnosis.38
Discussion
This systematic review has found that migrants, largely those from
HIV-endemic countries, are at high risk of HIV infection and its
consequences.10,11,13,14,23–25,27,38,40,45 Their HIV prevalence is higher
than that of the general population, they have a higher frequency of
delayed HIV diagnosis and are more vulnerable to the negative
effects of disclosure of HIV status.11,16 For migrants from
countries where HIV prevalence is low, their socio-economic vul-
nerability puts them at risk of acquiring HIV in destination
countries.11,39,40 In addition to their socio-economic vulnerability
and the barriers to HIV testing shared with other groups at risk,
migrants have specific legal and administrative impediments to
accessing health services10,16,17,24 and thus HIV testing facilities—
in some countries, undocumented migrants are not entitled to
health care13,14,35—as well as cultural and linguistic barriers,14–18,20
racism and xenophobia10; criminalization of HIV transmission has
disproportionately affected migrants from SSA.10 Migrants also fear
stigma and discrimination from their communities, fundamental for
their well-being in a foreign country.10
Testing migrants for HIV may take place either in the context of
general population strategies in health-care settings—such as
antenatal testing—or targeted approaches among specific popula-
tions. HIV testing uptake in antenatal settings in migrants is high
and similar to that of non-migrant women. Women from
HIV-endemic countries prefer general population strategies that
are integrated within health services.33,42 Overall, a higher
proportion of migrant women have been tested for HIV compared
with men, partially because of high acceptance of routine antenatal
HIV screening, but men, although less exposed to HIV testing, are
also less willing to be tested.29 Reaching migrant men, both hetero-
sexual and MSM, is a challenge. The literature shows that migrant
HIV testing for migrant populations in high-income countries 1043








MSM are a hard-to-reach group and that ‘machismo’ and
homophobia are deterrents to HIV prevention.27 Mandatory HIV
testing for migrants and asylum seekers when entering a country, in
place in some settings,30,31,47 violates the core principles that HIV
testing must be confidential, voluntary and performed with
informed consent.
A key aspect—often undermined—is the heterogeneity of migrant
populations, which requires tailored strategies for some groups. It is
essential to discuss and implement interventions in partnerships
with the communities. Test performance in non-traditional
settings27,36,41 and during off-hours,29 the use of rapid tests12,29,36
and providing test services from a culturally sensitive perspective
appear to be positive interventions. It is remarkable that little infor-
mation on counselling was retrieved from the literature.
There are a number of study limitations that merit discussion.
Although our aim was not to review studies on HIV prevalence and
risk factors in migrants and ethnic minorities, these subjects came
up in a large number of studies. However, we realize that the search
strategy used provides only a partial view on these topics. We are
also aware this search covers only articles in English; research in
other languages, the grey literature and conference abstracts are
not included. The methodology used in this systematic review
does not permit a comprehensive assessment of the extent to
which mandatory HIV testing is applied to migrants.
There is increasing evidence in recent years of the benefits of HIV
testing at the individual and community levels.5,48–52 There is also
overwhelming consensus that HIV testing cannot be the final goal,
and it is essential to link testing with care, support and treatment so
as to ensure a referral pathway for those who test positive. In
December 2010, the European Centre for Disease Prevention and
Control (ECDC) launched ‘HIV testing: increasing uptake and ef-
fectiveness in the European Union’8 in which migrants receive con-
siderable attention. The results from this systematic review may help
to design interventions targeting migrants, so that ECDC guidance
may influence national recommendations.
Supplementary Data
Supplementary Data are available at EURPUB online.
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Key points
 Migrants, mainly from HIV-endemic countries, are at high
risk of HIV infection and its consequences. Their HIV
prevalence is higher than in the general population, they
have higher frequency of delayed HIV diagnosis and are
more vulnerable to the negative effects of disclosure of
HIV status. For migrants from countries with low HIV
prevalence, socio-economic vulnerability puts them at risk
of acquiring HIV in destination countries.
 Migrants have specific legal and administrative impediments
in accessing health services and HIV testing—in some
countries, undocumented migrants are not entitled to
health care—as well as cultural and linguistic barriers,
racism and xenophobia. Migrants fear stigma from their
communities, yet community acceptance is key for well-being.
 Although there is increasing evidence of the benefits of HIV
testing at both the individual and community levels, the
barriers highlighted in this systematic review may prevent
programs from achieving the final goal, which is linking
migrants and ethnic minorities to HIV clinical care under
the public health perspective.
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